Stock NHC NATIONAL HEALTHCARE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages National HealthCare Corporation

Equities

NHC

US6359061008

Market Closed - Nyse
Other stock markets
 21:10:00 10/05/2024 BST 		5-day change 1st Jan Change
94.95 USD -1.12% Intraday chart for National HealthCare Corporation +3.80% +2.74%
05-10 National HealthCare Q1 Non-GAAP Earnings, Revenue Advance MT
05-10 Earnings Flash (NHC) NATIONAL HEALTHCARE CORPORATION Posts Q1 Revenue $297.2M MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
National HealthCare Q1 Non-GAAP Earnings, Revenue Advance
National Healthcare Corporation Declares Quarterly Dividend, Payable on August 1, 2024
Land & Buildings Issues Letter to Shareholders of National Health Investors
National HealthCare's Q4 Adjusted Earnings, Revenue Increase
National HealthCare Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
National HealthCare Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
NHC Announces Quarterly Common Dividend, Payable on May 1, 2024
Perimeter Medical Imaging AI Provides Update
Revenue from China's Basic Medical Insurance Reaches 2.7 Trillion Yuan in 2023
Perimeter Medical Imaging AI Announces Further Commercial Expansion in North Texas
Zai Lab Shares Climb as Vyvgart, Nuzyra, Zejula Added to 2023 China Reimbursement Drug List
Sector Update: Health Care Stocks Stronger Late Afternoon
Zai Lab Says China Added Vyvgart, Nuzyra, Zejula to 2023 Reimbursement Drug List
HUTCHMED's Metastatic Colorectal Cancer, Neuroendocrine Tumors Drugs to Remain on China's National Reimbursement Drug List
National Healthcare Insider Sold Shares Worth $663,750, According to a Recent SEC Filing
National Healthcare Insider Sold Shares Worth $641,250, According to a Recent SEC Filing
Revenue of China’s Basic Medical Insurance Fund Hits 2.6 Trillion Yuan in January-October
Two Luoxin Pharma Drugs Selected in China’s National Drug Procurement Program
Joincare Pharma Shortlisted For China’s Drug Procurement Program
National Healthcare Corporation Announces Quarterly Dividend, Payable on February 1, 2024
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NHC Stock
  4. News National HealthCare Corporation
  5. Other languages